Network Immunology Inc. ("NI") is a leading edge, Vancouver based biotech company developing a revolutionary immunotherapeutic platform called AbstimX™.

Treatment with AbstimX™ re-balances and resets overactive immune systems, long-term.

AbstimX™ has been shown to be applicable to many inflammatory diseases.

In pre-clinical studies, AbstimX™ therapy has safely and effectively treated and prevented the development of a broad range of inflammatory diseases - from chronic allergies to autoimmunity.

Mission and Vision:

Our mission, is to majorly decrease the amount of suffering caused by inflammatory diseases, on a global scale.

Our vision, is a world in which everyone has access to AbstimX™.

Our Business Model:

At Network Immunology, we create substantial and lasting value through the development of novel immunotherapeutics for licensing and commercialization of those products and their associated intellectual property.

We invite you to join us on this journey to the commercialization of AbstimX™.

Network Immunology

Org chart

Teams

Offices